Celator Pharmaceuticals Inc 4
4 · Celator Pharmaceuticals Inc · Filed Mar 17, 2016
Insider Transaction Report
Form 4
Mayer Lawrence David
President and Head of Research
Transactions
- Tax Payment
Common Stock
2016-03-15$8.94/sh−12,081$108,004→ 107,515 total - Exercise/Conversion
Common Stock
2016-03-15$2.25/sh+48,002$108,005→ 119,596 total - Exercise/Conversion
Stock Option, Right to Buy
2016-03-15−48,002→ 0 totalExercise: $2.25Exp: 2016-03-22→ Common Stock (48,002 underlying)
Holdings
- 7,468(indirect: By Spouse)
Common Stock
- 3,631(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These options are fully exercisable.